IL-6 is central to both innate and adaptive immunity in rhesus macaques:
Viral Infections: During SFTSV infection, IL-6 correlates with activated T/B cells, NK cells, and monocytes, driving proinflammatory responses . In SIV-infected macaques, IL-6 expression in brain microglia precedes detectable viral loads, suggesting early neuroinflammatory involvement .
Aging: Plasma IL-6 levels rise significantly in middle-aged macaques (8–17 years), paralleling increases in neurofilament light chain (NfL) and marking immunosenescence .
COVID-19: In SARS-CoV-2-infected macaques, IL-6 mRNA is abundant in pulmonary lesions, reflecting its role in acute respiratory inflammation .
Commercial ELISA kits enable precise quantification of IL-6 in macaque samples:
Kit | Sensitivity | Range | Sample Types |
---|---|---|---|
Sigma-Aldrich RAB0931 | 40 pg/mL | 40.96–10,000 pg/mL | Serum, plasma, tissue homogenates |
U-CyTech CT145A | 2 pg/mL | 2–128 pg/mL | Serum, plasma, culture supernatant |
These assays show minimal cross-reactivity with related cytokines and high reproducibility (intra-assay CV <10%) .
IL-6 increases during middle adulthood (8–17 years) in rhesus macaques, coinciding with elevated NfL and chronic inflammation .
Age-related IL-6 surges mirror human "inflamm-aging," linked to immunosenescence and metabolic dysregulation .
SFTSV: IL-6 correlates with viral load (r = 0.72) and body temperature (r = 0.65), highlighting its role in febrile responses .
SIV: Brain IL-6 expression at 7 days post-infection (dpi) precedes viral detection, implicating microglial activation in neuropathology .
SARS-CoV-2: Pulmonary IL-6 mRNA peaks at 4–5 dpi, correlating with macrophage infiltration and lesion severity .
IFN-b2, B cell differentiation factor, BCDF, BSF-2, HPGF, HSF, MGI-2, B-cell stimulatory factor 2, IFN beta-2, Hybridoma growth factor, CTL differentiation factor, CDF, IL-6, HGF.
Interleukin-6 (IL-6) in Rhesus Macaques is a critical proinflammatory cytokine that plays a pivotal role in immune modulation and signaling. It functions as a key player in immune cell activation and inflammatory responses, providing researchers with valuable insights into cytokine-mediated functions. IL-6 Rhesus Macaque Recombinant is particularly valuable in immunological exploration, allowing researchers to investigate immune dynamics in a non-human primate model that closely resembles human immune system functioning. The protein has several synonyms including DIF, TNFA, and TNFSF2, reflecting its complex role in immune signaling networks .
In immunological research, IL-6 serves as an important biomarker for investigating inflammatory processes, immune regulation, and the development of immune-related disorders. Its molecular structure and interactions contribute significantly to the fine-tuning of immune responses, making it an essential target for studies focused on understanding cytokine networks and their implications in health and disease .
IL-6 functions within a complex network of proinflammatory cytokines in Rhesus Macaques, interacting closely with Interleukin-1 (IL-1) and Tumor Necrosis Factor-alpha (TNF-α). These cytokines stimulate the release of one another, forming a sophisticated cascade system. Research has shown that both IL-1α and IL-1β are equally effective at elevating blood levels of IL-6 in juvenile Rhesus Monkeys following intravenous administration. This demonstrates the upstream regulatory role of IL-1 on IL-6 production in the peripheral circulation .
Interestingly, there is tissue specificity in these interactions. While both IL-1α and IL-1β stimulate IL-6 production in blood, IL-1β specifically and significantly elevates IL-6 levels in the cerebrospinal fluid (CSF), suggesting a unique role for IL-1β in central nervous system (CNS) inflammation. Additionally, both IL-1 and IL-6 increase levels of IL-1 receptor antagonist (IL-1ra) in the blood and comparably stimulate the release of cortisol, demonstrating the complex regulatory mechanisms within this cytokine network .
The cytokine cascade typically follows a sequential pattern during inflammatory challenges, with TNF-α appearing first, followed by IL-1 and finally IL-6. This temporal pattern is essential for researchers to consider when designing studies examining immune responses in Rhesus Macaque models .
IL-6 plays a crucial role in neurodevelopmental research with Rhesus Macaque models, particularly in understanding how maternal immune activation affects offspring brain development. Studies have demonstrated that maternal IL-6 levels during pregnancy are significantly associated with offspring amygdala volume development and anxiety-like behavior in Japanese macaques. Specifically, increased maternal third trimester plasma IL-6 levels correlate with smaller left amygdala volume in offspring at 4 months of age, but interestingly, with more rapid amygdala growth from 4 to 36 months .
This bidirectional relationship suggests that IL-6 may initially suppress amygdala development but subsequently trigger compensatory growth mechanisms. Furthermore, maternal IL-6 predicts offspring anxiety-like behavior at 11 months, which is mediated by reduced amygdala volumes at 4 months. This mediation pathway provides valuable insights into the neurobiological mechanisms linking maternal inflammation to offspring behavioral outcomes .
These findings are particularly significant as they extend our understanding of how maternal inflammatory processes may contribute to neurodevelopmental disorders in humans. The longitudinal nature of these studies, covering the equivalent timeframe of human infancy into puberty, makes Rhesus Macaque models especially valuable for investigating the developmental trajectory of inflammation-related neuropsychiatric conditions .
When investigating IL-6 in the Rhesus Macaque central nervous system (CNS), researchers should employ a multi-modal approach combining imaging, molecular, and behavioral assessments. The most effective methodological strategies include:
Cerebrospinal Fluid (CSF) Sampling: Direct measurement of IL-6 levels in CSF provides accurate assessment of central cytokine activity. Studies have confirmed that IL-6 detected in CSF following peripheral IL-1β administration is brain-derived rather than resulting from blood diffusion, necessitating proper CSF collection techniques .
Longitudinal Magnetic Resonance Imaging (MRI): Serial MRI measurements allow researchers to track developmental trajectories of brain structures affected by IL-6. In studies examining maternal IL-6 effects on offspring, MRI scans at multiple time points (e.g., 4, 11, 21, and 36 months of age) enable the detection of both immediate and long-term neuroanatomical changes, particularly in structures like the amygdala .
Behavioral Assessments: Standardized behavioral testing paradigms for anxiety-like behaviors provide functional correlates to neuroanatomical changes associated with IL-6. These assessments should be timed to correspond with critical developmental windows and imaging timepoints to establish brain-behavior relationships .
RNA Sequencing: RNA-Seq analysis of brain tissues allows for comprehensive evaluation of IL-6 signaling pathways and downstream gene expression changes. This approach has successfully identified upregulation of cytokine signaling pathways, including IL-6, IL-10, and IL-27, in the frontal cortex of macaques at 14 days post-infection in viral models .
Immunohistochemistry: Cellular localization of IL-6 expression through immunohistochemical staining enables identification of specific cell populations (e.g., microglia, astrocytes) responsible for IL-6 production in different brain regions .
These methodological approaches, when used in combination, provide comprehensive insights into the role of IL-6 in the Rhesus Macaque CNS across various experimental contexts.
Differentiating between centrally and peripherally produced IL-6 in Rhesus Macaque studies requires sophisticated methodological approaches:
Comparative Sampling: Simultaneous collection and analysis of blood and cerebrospinal fluid (CSF) samples allows researchers to compare IL-6 concentrations and kinetics between these compartments. Studies have demonstrated that IL-6 levels in blood and CSF can be differentially affected by various stimuli. For instance, while both IL-1α and IL-1β effectively elevate blood IL-6 levels, only IL-1β significantly elevates IL-6 in the CSF of juvenile Rhesus Macaques .
Pharmacokinetic Analysis: Tracking the temporal profile of IL-6 appearance in CSF versus blood after peripheral immune challenge can help determine the source. Research has confirmed that IL-1-induced IL-6 in CSF is brain-derived rather than resulting from diffusion from blood, based on careful pharmacokinetic analysis .
Cellular Origin Identification: Immunohistochemical techniques combined with flow cytometry can identify the specific cell types producing IL-6 in different tissues. For example, IL-6-expressing microglia can be identified using markers such as Iba-1 together with IL-6, allowing researchers to quantify parenchymal versus perivascular microglial production of IL-6 .
Regional Brain Analysis: Examining IL-6 expression across different brain regions can provide insights into central production patterns. Studies have found that the basal ganglia and thalamus may have different IL-6 expression profiles compared to the frontal cortex, suggesting region-specific central production .
RNA-Seq Analysis: Transcriptomic profiling of brain tissues versus peripheral blood mononuclear cells (PBMCs) can reveal distinct IL-6 signaling signatures. Research has shown that IL-6 signaling pathways can be upregulated in brain tissues (frontal cortex, thalamus, basal ganglia) even when peripheral viral loads remain low, indicating independent central production mechanisms .
By employing these approaches, researchers can reliably distinguish between IL-6 produced within the CNS versus that originating from peripheral sources, which is crucial for understanding the role of IL-6 in neuroinflammatory conditions and neurodevelopmental processes.
The relationship between IL-6 expression and Simian Immunodeficiency Virus (SIV) infection in the Rhesus Macaque brain reveals a complex temporal and spatial pattern with significant implications for understanding HIV-associated neuroinflammation in humans:
This relationship between IL-6 expression and SIV infection provides a valuable model for understanding early neuroinflammatory responses in HIV infection and suggests that IL-6 may be an early biomarker for CNS viral invasion and subsequent neuroinflammation.
Maternal IL-6 exerts a complex, time-dependent influence on amygdala development in Rhesus Macaque offspring, with significant implications for understanding the relationship between maternal inflammation and neurodevelopmental outcomes:
Biphasic Developmental Effect: Research demonstrates that increased maternal third trimester plasma IL-6 levels are associated with smaller left amygdala volume in offspring at 4 months of age (B = -0.744, P < 0.001), but paradoxically predict more rapid amygdala growth from 4 to 36 months (B = 0.451, P = 0.004). This suggests a biphasic effect where initial developmental suppression is followed by accelerated compensatory growth .
Growth Trajectory Alterations: The relationship between maternal IL-6 and amygdala development can be visualized through growth trajectories. When subjects are categorized into high and low IL-6 groups using a median split, those exposed to higher maternal IL-6 show initially smaller amygdala volumes followed by steeper growth curves compared to the low IL-6 group. This pattern remains evident even after controlling for total brain volume (TBV) .
Mediation of Behavioral Outcomes: Maternal IL-6 levels indirectly influence offspring anxiety-like behavior through effects on amygdala development. Higher amygdala volumes at 4 months of age significantly predict lower anxiety-like behavior at 11 months (B = -0.779, P = 0.014). While there is no significant direct effect of IL-6 on anxiety (B = -0.574, P = 0.062), a significant indirect effect exists via amygdala volume at 4 months (B = 0.580, P = 0.039) .
The table below summarizes the key statistical relationships between maternal IL-6, amygdala volume, and anxiety-like behavior:
Relationship | Parameter Estimate (B) | P-value | Interpretation |
---|---|---|---|
IL-6 → Amygdala Volume Intercept | -0.744 | <0.001 | Higher maternal IL-6 predicts smaller initial amygdala volume |
IL-6 → Amygdala Volume Slope | 0.451 | 0.004 | Higher maternal IL-6 predicts faster amygdala growth rate |
Amygdala Volume → Anxiety Behavior | -0.779 | 0.014 | Larger initial amygdala volume predicts less anxiety-like behavior |
IL-6 → Anxiety (Direct Effect) | -0.574 | 0.062 | No significant direct effect |
IL-6 → Anxiety (Indirect Effect via Amygdala) | 0.580 | 0.039 | Significant mediation effect through amygdala volume |
These findings highlight the importance of considering developmental trajectories rather than single time points when studying the impact of maternal inflammation on offspring neurodevelopment. They also suggest potential mechanisms by which maternal immune activation may contribute to the development of anxiety disorders and other neurobehavioral conditions in offspring .
IL-6 Rhesus Macaque research offers several promising applications for understanding human immunological disorders, leveraging the close physiological similarities between macaques and humans:
Neuroinflammatory Disease Modeling: The finding that IL-6 expression precedes viral detection in the brain during SIV infection provides a valuable model for studying early neuroinflammatory processes in HIV-associated neurocognitive disorders (HAND). This temporal relationship suggests that targeting IL-6 signaling early in infection might prevent subsequent neurological damage .
Maternal Immune Activation and Neurodevelopmental Disorders: The established relationship between maternal IL-6 levels and offspring amygdala development offers insights into how maternal inflammation might contribute to neurodevelopmental disorders such as autism spectrum disorder (ASD) and schizophrenia. The longitudinal nature of these studies allows researchers to track developmental trajectories from infancy through adolescence, providing a more comprehensive understanding than is possible in human studies .
Cytokine Network Interactions in Inflammatory Conditions: Research on the proinflammatory cytokine network in Rhesus Macaques demonstrates how IL-6 functions within a complex cascade involving IL-1 and TNF-α. Understanding these interactions can inform therapeutic approaches for inflammatory conditions where cytokine dysregulation plays a central role, such as rheumatoid arthritis, inflammatory bowel disease, and cytokine release syndrome .
Brain-Periphery Immune Communication: Studies distinguishing between centrally and peripherally produced IL-6 in Rhesus Macaques provide essential insights into how peripheral immune activation influences central nervous system function. This research has direct relevance for understanding conditions where peripheral inflammation contributes to neuropsychiatric symptoms, such as depression, anxiety disorders, and neurodegenerative diseases .
Therapeutic Development and Target Validation: IL-6 Rhesus Macaque Recombinant serves as a valuable tool for preclinical validation of IL-6-targeted therapeutics. Its molecular insights, pivotal functions, and potential implications position it as a critical asset for advancing our understanding of immune regulation and developing novel interventions for immune-related diseases .
These applications highlight the translational value of IL-6 Rhesus Macaque research, bridging the gap between basic immunological research and clinical applications in human immunological disorders.
Researchers designing longitudinal studies of IL-6 in Rhesus Macaques face several methodological challenges that must be carefully addressed to ensure valid and reliable results:
Individual Variability Management: Rhesus Macaques exhibit significant individual variability in baseline IL-6 levels and responses to immune challenges. For example, in studies of SIV infection, plasma viral loads at 14 days post-infection ranged from 4.38 to 8.11 log10 SIV Gag RNA copies/mL among five macaques . Researchers should implement:
Larger sample sizes to account for variability
Matched control designs where animals serve as their own controls
Statistical approaches that account for individual baselines, such as mixed-effects models
Developmental Timing Considerations: When studying developmental effects of IL-6, precise timing of assessments is crucial. Research has shown that the relationship between maternal IL-6 and offspring amygdala volume changes dramatically between 4 months and 36 months . Longitudinal designs should:
Include multiple assessment points across developmental stages
Align assessment timing with known developmental milestones in Rhesus Macaques
Consider age-specific normative data for interpretation
Regional Tissue Specificity: Different brain regions may show distinct patterns of IL-6 expression and sensitivity. Studies have found that the basal ganglia and thalamus had detectable virus earlier (7 dpi) than the frontal cortex (14 dpi) during SIV infection . Researchers should:
Sample multiple brain regions when possible
Interpret region-specific findings cautiously without generalizing to the entire brain
Consider region-specific baseline differences in IL-6 expression
Integration of Multiple Outcome Measures: Comprehensive assessment of IL-6 effects requires integration of molecular, structural, and behavioral outcomes. Studies linking maternal IL-6 to offspring outcomes successfully combined plasma measurements, brain imaging, and behavioral assessments . Researchers should:
Develop protocols that coordinate timing of different assessments
Employ statistical approaches for mediation and moderation analyses
Consider both direct and indirect effects of IL-6 on outcomes of interest
Technical Standardization: Longitudinal studies require consistent measurement techniques across time points. Researchers should:
Standardize sample collection, processing, and storage procedures
Use the same assay platforms and reagents across time points
Implement quality control measures, including regular calibration of equipment and inclusion of reference samples
Addressing these methodological challenges requires careful planning, robust statistical approaches, and consideration of both biological and technical sources of variability in longitudinal IL-6 research with Rhesus Macaques.
Translating findings from IL-6 Rhesus Macaque studies to human research requires systematic approaches that acknowledge both the similarities and differences between species while leveraging the unique advantages of macaque models:
Comparative Genomics and Proteomics: Researchers should conduct detailed comparisons of IL-6 structure, signaling pathways, and receptor interactions between Rhesus Macaques and humans. While IL-6 is highly conserved across primates, subtle species differences may influence drug responses or pathophysiological mechanisms. Computational approaches comparing genomic and proteomic data can identify these differences and inform translation strategies .
Parallel Biomarker Development: Findings such as the predictive value of maternal IL-6 for offspring neurodevelopment can be translated through parallel biomarker studies in human cohorts. For example, the observation that maternal IL-6 predicts offspring amygdala volume and anxiety-like behavior in macaques could guide the development of similar biomarkers in human maternal-infant cohorts, focusing on comparable developmental windows adjusted for human development.
Methodological Harmonization: When designing human studies based on macaque findings, researchers should harmonize methodological approaches as much as possible. For instance, the longitudinal MRI protocols used to track amygdala development in macaques could be adapted for human developmental neuroimaging studies, with timing adjusted to account for species differences in developmental trajectories.
Integrated Multimodal Assessment: The comprehensive approach used in macaque studies integrating cytokine measurements, brain imaging, and behavioral assessments provides a template for human studies. Translational research should similarly combine multiple assessment modalities to capture the complex relationships between IL-6, brain development, and behavior in humans.
Temporal Dynamics Consideration: The finding that IL-6 expression precedes viral detection in the macaque brain during SIV infection suggests that early IL-6 responses might serve as early biomarkers for neuroinflammation in humans. Human studies should similarly focus on temporal dynamics, potentially using cerebrospinal fluid IL-6 measurements as early indicators of neuroinflammatory processes in HIV and other conditions.
Translation to Clinical Interventions: The understanding of IL-6's role in immune signaling networks derived from macaque studies can inform targeted therapeutic approaches in humans. The identification of specific pathways, such as IL-6/JAK/STAT3 signaling , provides potential targets for intervention in human inflammatory conditions, with macaque studies serving as crucial preclinical validation models.
By systematically addressing these translation strategies, researchers can maximize the clinical relevance of findings from IL-6 Rhesus Macaque studies while acknowledging the inherent limitations of cross-species extrapolation.
Interleukin-6 (IL-6) is a multifunctional cytokine that plays a crucial role in immune response, inflammation, and hematopoiesis. The recombinant form of IL-6 derived from Rhesus macaques is particularly valuable for research due to its close genetic similarity to humans, making it an excellent model for studying human diseases and immune responses.
The IL-6 protein in Rhesus macaques is composed of 212 amino acids and has a molecular weight of approximately 21.1 kDa . It is typically expressed in Escherichia coli (E. coli) systems, which allows for high-yield production and easy purification . The recombinant IL-6 is often lyophilized for storage and can be reconstituted in sterile distilled water for experimental use .
IL-6 is known for its role in inducing B-cell differentiation and acting as a primary regulator of inflammation . It has been shown to regulate tumor proliferation and inhibit apoptosis, contributing to the progression of diseases such as coronary artery disease . The biological activity of recombinant IL-6 is measured using cell proliferation assays, with an effective dose (ED50) of less than 0.1 ng/mL, indicating its high potency .
Recombinant IL-6 from Rhesus macaques is used extensively in various research applications, including: